Lung Disease in Systemic Sclerosis
ACR on Air
00:00
Treatment Approaches for Interstitial Lung Disease in Systemic Sclerosis Patients
Exploring the decision-making process for initiating immunosuppressive therapy for ILD in systemic sclerosis patients, focusing on personalized treatment plans tailored to individual patient factors. Delving into options like MMF as first-line therapy and discussing alternative medications for progressive SSCILD, alongside considerations for monitoring and management of pulmonary hypertension in systemic sclerosis patients through multidisciplinary collaboration.
Play episode from 27:38
Transcript
